SHOW / EPISODE

The Blueprint Betrayal

Season 1 | Episode 13
31m | Aug 18, 2026

In the mid-2000s, Silicon Valley elites and Hollywood stars gathered at swanky "spit parties" to fill plastic test tubes with saliva. They were ushering in a utopian promise: direct-to-consumer genetic testing that would democratize healthcare. Leading the charge was 23andMe and its charismatic CEO, Anne Wojcicki.

Fast forward to today, and that utopian dream has collapsed into a cautionary tale of corporate hubris, dark web data sales, and federal bankruptcy auctions. In this episode of THE ARTIFACT: True Stories of Fraud, Ego, and the Lies We Call Fact, we examine the rise and fall of 23andMe—from its initial FDA showdowns to the catastrophic 2023 credential-stuffing breach that exposed nearly 7 million users. We pull back the curtain on the $305 million bankruptcy buyout by Wojcicki’s non-profit, TTAM Research Institute (ChromeCo), and expose the uncomfortable truths behind "open medical research," fine-print consent, GLP-1 weight-loss drug monetization, and the legal illusion of hitting "delete" on your personal DNA.

Paused
Audio Player Image
THE ARTIFACT: True Stories of Fraud, Ego, and the Lies We Call Fact
Loading...